CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

Publish Year: 1387
نوع سند: مقاله ژورنالی
زبان: English
View: 151

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RYA-4-1_008

تاریخ نمایه سازی: 3 شهریور 1401

Abstract:

Abstract    BACKGROUND: Access to vascular system needed for hemodialysis among patients in end stage renal disease (ESRD). Cardiac performance has been affected by chronic renal failure based on several known causes during diseases process. We have compared in this study some of cardiac performance indicators before and after fistulization in diabetic and non-diabetic ESRD patients.    METHODS: Fifty ESRD patients were included in the study. Systolic pulmonary arterial pressure (PAP), cardiac output (CO) and ejection fraction (EF) were measured by echocardiography before fistulization and was repeated at least ۸ months after fistulization. Data analyzed in diabetic and non-diabetic patients. RESULTS: Thirty four patients were included in analysis (۲۸ men and ۶ women). Mean time of follow up was ۱۰.۵ ± ۱.۳ months. The mean of PAP before and after fistulization was ۲۵.۱۶ mmHg and ۲۱.۳ mmHg, respectively in all individuals (P > ۰.۰۵). The mean of cardiac output before and after making fistula was ۵۵۸۰ ml/min and ۵۶۸۰ ml/min, respectively (P < ۰.۰۵). Diabetic patients showed a significant reduction in their mean of cardiac ejection fraction before and after intervention (EF۱ = ۶۶.۹%, EF۲ = ۵۱.۴%) comparing with non-diabetic patients (EF۱ = ۵۸.۵, EF۲ = ۵۷.۵) (P < ۰.۰۵). PAP changes and CO changes had not any significant difference between diabetic and non-diabetic patients. DISCUSSION: Fistulization in ESRD patients can improve cardiac performance among these patients. This change may be differing among patients based on the cause of renal failure. Diabetes mellitus may be one of the parameters that can modulate this affect. This should be test in more detailed studies.      Keywords: Fistulization, End Stage Renal Diseases, Cardiac Performance, Diabetes mellitus

Authors

Ali-Akbar Beigi

Assistant Professor, Vascular surgery department, Chamran Hospital, Isfahan University of Medical Sciences, Isfahan.

Alireza Khosravi

Assistant Professor, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan.

Amir Mir-Mohammad Sadeghi

Assistant Professor, Department of General Surgery, Kashan University of Medical Scienses, Kashan.

Mansour Safaei

Associate Professor, Department of Surgery, Isfahan University of Medical Sciences, Isfahan.